Blaser Brian J. 4

What Happened Brian J. Blaser, President and CEO of QuidelOrtho Corporation (QDEL), received a grant of 213,470 restricted stock units (RSUs) on January 30, 2026. The award is reported as a derivative acquisition at $0.00 because no cash was exchanged at grant; each RSU represents the right to receive one share of common stock upon vesting. This is a compensation award rather than an open-market purchase or sale.

Key Details

• Transaction date: January 30, 2026; Form 4 filed February 3, 2026. No late-filing indicator is noted in the report.
• Instrument and amount: 213,470 restricted stock units (derivative award) reported at $0.00.
• Vesting schedule (per filing footnotes): 71,156 RSUs vest on Jan 30, 2027; the remaining 142,314 RSUs vest in equal installments on Jan 30, 2028 and Jan 30, 2029.
• Shares owned after the transaction: not specified in the filing.
• No 10b5-1 plan, tax-withholding sale, or cashless exercise is disclosed in the filing.

Context RSU grants are common executive compensation and do not involve an immediate purchase or sale of shares; they convert into actual shares only when they vest. Because this is an award, it signals company compensation policy rather than an insider buying or selling stock in the market.